FindTrial
Sign In

Stadradization in the dosage of Nasal Errhine treatment in healthy individuals

Standardization of Bindu Pramana Dose in Nasya Karma with special reference to age and Nasya Dravya Kalpana for Clinical practice - an observational study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/098145
Enrollment
300
Registered
2025-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Sushrutha Ayurvedic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria- a).Healthy volunteers b).Age group between 16 to 80 years

Exclusion criteria

Exclusion criteria: Exclusion criteria a).Anatomical defect in hands. b). Injured index finger.

Design outcomes

Primary

MeasureTime frame
Dosage of different formulations used in the nasal errhine treatmentTimepoint: 3 months—

Secondary

MeasureTime frame
Dosage of different formulations used in Nasya with respect to ageTimepoint: 3 months—

Countries

India

Contacts

Public ContactAditi Patil

Sushrutha Ayurvedic Medical College and Hospital

aditi200423@gmail.com9449316017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026